Published in Medical Letter on the CDC and FDA, September 6th, 2009
As anticipated, the Ministry of Health, Labour and Welfare's Expert Meeting II was held at the end of July in Japan, at which time the STAAR Visian ICL products were considered for approval in the Japanese market. The Company has received formal written feedback within the anticipated timeline. This feedback includes formal requests for additional information regarding potential labeling and long-term clinical data. STAAR will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA